Paper23336
Characterization and development of cimetidine as a histamine H2-receptor antagonist.
Brimblecombe RW and 6 others. Gastroenterology, 1978. Cited by 199 papers, by iCite.
Cite this record
ConductScience Library. Characterization and development of cimetidine as a histamine H2-receptor antagonist. Papers, record 23336. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23336
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cimetidine | Major topic |
| Guanidines | Major topic |
| Androgen Antagonists | |
| Animals | |
| Chemical Phenomena | |
| Chemistry | |
| Dogs | |
| Dose-Response Relationship, Drug | |
| Drug Interactions | |
| Female | |
| Gastric Juice | |
| Gastric Mucosa | |
| Guinea Pigs | |
| Histamine H2 Antagonists | |
| Kinetics | |
| Lethal Dose 50 | |
| Male | |
| Rats |
Source PubMed
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 199 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36677894 | Imidazole: Synthesis, Functionalization and Physicochemical Properties of a Privileged Structure in Medicinal Chemistry. | Molecules | 2023 | https://conductscience.org/library/papers/36677894 | PubMed |
| 34247436 | Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections-Exploratory study. | Helicobacter | 2021 | https://conductscience.org/library/papers/34247436 | PubMed |
| 32932742 | Agonist Binding and G Protein Coupling in Histamine H2 Receptor: A Molecular Dynamics Study. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32932742 | PubMed |
| 30462522 | Distinct roles of histamine H1- and H2-receptor signaling pathways in inflammation-associated colonic tumorigenesis. | Am J Physiol Gastrointest Liver Physiol | 2019 | https://conductscience.org/library/papers/30462522 | PubMed |
| 30013459 | Protective Effects of Methanol Extract of Vernonia amygdalina (del.) Leaf on Aspirin-Induced Gastric Ulceration and Oxidative Mucosal Damage in a Rat Model of Gastric Injury. | Dose Response | 2018 | https://conductscience.org/library/papers/30013459 | PubMed |
| 27625606 | Activation of Muscarinic Acetylcholine Receptor Subtype 4 Is Essential for Cholinergic Stimulation of Gastric Acid Secretion: Relation to D Cell/Somatostatin. | Front Pharmacol | 2016 | https://conductscience.org/library/papers/27625606 | PubMed |
| 25572737 | In silico modeling of the molecular interactions of antacid medication with the endothelium: novel therapeutic implications in head and neck carcinomas. | Int J Immunopathol Pharmacol | 2014 | https://conductscience.org/library/papers/25572737 | PubMed |
| 25389436 | The effects of baclofen for the treatment of gastroesophageal reflux disease: a meta-analysis of randomized controlled trials. | Gastroenterol Res Pract | 2014 | https://conductscience.org/library/papers/25389436 | PubMed |
| 23807824 | Non-imidazole histamine H3 ligands: part V. synthesis and preliminary pharmacological investigation of 1-[2-thiazol-4-yl- and 1-[2-thiazol-5-yl-(2-aminoethyl)]-4-n-propylpiperazine derivatives. | Med Chem Res | 2013 | https://conductscience.org/library/papers/23807824 | PubMed |
| 16645899 | Gastric H,K-ATPase as a drug target. | Dig Dis Sci | 2006 | https://conductscience.org/library/papers/16645899 | PubMed |
| 12620858 | Synthesis of imidazol-2-yl amino acids by using cells from alkane-oxidizing bacteria. | Appl Environ Microbiol | 2003 | https://conductscience.org/library/papers/12620858 | PubMed |
| 11219486 | Nephrotoxicity and hepatotoxicity of histamine H2 receptor antagonists. | Drug Saf | 2001 | https://conductscience.org/library/papers/11219486 | PubMed |
| 7859585 | Safety of acid-suppressing drugs. | Dig Dis Sci | 1995 | https://conductscience.org/library/papers/7859585 | PubMed |
| 7342462 | Cimetidine and cytopenia. | West J Med | 1981 | https://conductscience.org/library/papers/7342462 | PubMed |
| 7129629 | Arousal of mucosal secretory immunoglobulin A antitoxin in rats immunized with Escherichia coli heat-labile enterotoxin. | Infect Immun | 1982 | https://conductscience.org/library/papers/7129629 | PubMed |
| 7019087 | Immunization of rats with heat-labile enterotoxin provides uniform protection against heterologous serotypes of enterotoxigenic Escherichia coli. | Infect Immun | 1981 | https://conductscience.org/library/papers/7019087 | PubMed |
| 7011992 | Respective contributions to protection of primary and booster immunization with Escherichia coli heat-labile enterotoxin in rats. | Infect Immun | 1981 | https://conductscience.org/library/papers/7011992 | PubMed |
| 7011990 | Protective effect of immunization of rats with holotoxin or B subunit of Escherichia coli heat-labile enterotoxin. | Infect Immun | 1981 | https://conductscience.org/library/papers/7011990 | PubMed |
| 7000692 | Immunological cross-reactivity of heat-labile enterotoxins produced by enterotoxigenic and enteropathogenic strains of Escherichia coli. | Immunology | 1980 | https://conductscience.org/library/papers/7000692 | PubMed |
| 6991436 | Protective effect of immunization with heat-labile enterotoxin in gnotobiotic rats monocontaminated with enterotoxigenic Escherichia coli. | Infect Immun | 1980 | https://conductscience.org/library/papers/6991436 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23336
GET https://conductscience.org/api/papers/v1/23336/cited_by?page=2